Northwest Biotherapeutics (NWBO) News Today $0.36 +0.07 (+23.42%) As of 04/23/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Northwest Biotherapeutics: A Spike On Their Expected Imminent ApprovalApril 22 at 2:44 PM | seekingalpha.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below 200 Day Moving Average - Time to Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200 Day Moving Average - What's Next?April 20, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average - What's Next?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedApril 12, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Posts Quarterly Earnings ResultsNorthwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) announced its quarterly earnings data on Monday. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.23 million during the quarter.April 4, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Passes Below 200 Day Moving Average - Should You Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below 200-Day Moving Average - Here's WhyApril 2, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200 Day Moving Average - What's Next?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average - What's Next?March 22, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200 Day Moving Average - Should You Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200-Day Moving Average - What's Next?March 14, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200-Day Moving Average - Time to Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Pass Below Two Hundred Day Moving Average - Here's What HappenedMarch 6, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200-Day Moving Average - Here's What HappenedNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below Two Hundred Day Moving Average - Here's WhyFebruary 26, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below 200 Day Moving Average - What's Next?Northwest Biotherapeutics (OTCMKTS:NWBO) Share Price Passes Below 200-Day Moving Average - What's Next?February 20, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below 200-Day Moving Average - Time to Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?February 18, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200-Day Moving Average - Time to Sell?February 8, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200-Day Moving Average - Here's What HappenedNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200-Day Moving Average - What's Next?February 1, 2025 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedJanuary 31, 2025 | marketbeat.comInvestors Watching Two Small-Caps for News on Potential Major Advancements in Cancer TreatmentsJanuary 13, 2025 | msn.comNorthwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional FinancingDecember 26, 2024 | prnewswire.comNorthwest Biotherapeutics: All Is Not Well With This OneDecember 14, 2024 | seekingalpha.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200 Day Moving Average - Time to Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?November 9, 2024 | marketbeat.comBehind the Bell: Arcutis BiotherapeuticsNovember 5, 2024 | nasdaq.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below Two Hundred Day Moving Average - Here's WhyNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200-Day Moving Average - What's Next?October 26, 2024 | marketbeat.comNorthwest Registered Agent Review 2024: Features, Pricing & MoreOctober 24, 2024 | forbes.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average - What's Next?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200 Day Moving Average - Here's WhyOctober 8, 2024 | marketbeat.com0K95.IL,0P0000AFQ5,0 (0K95.IL)September 14, 2024 | nz.finance.yahoo.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Passes Below Two Hundred Day Moving Average of $0.44Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average of $0.44September 11, 2024 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below Two Hundred Day Moving Average of $0.46Northwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below 200 Day Moving Average of $0.46August 28, 2024 | marketbeat.comNorthwest Biotherapeutics addresses rumors and market activityAugust 4, 2024 | uk.investing.comNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth OpportunitiesJuly 3, 2024 | prnewswire.comNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO) Short Interest Down 14.0% in JuneNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 47,353,700 shares, a decline of 14.0% from the May 31st total of 55,038,700 shares. Based on an average daily volume of 2,945,900 shares, the short-interest ratio is currently 16.1 days.June 30, 2024 | marketbeat.comNorthwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual PropertyJune 17, 2024 | prnewswire.comNorthwest Biotherapeutics Inc (NWBO) Dividend HistoryMay 25, 2024 | nasdaq.comNorthwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of DirectorsMarch 21, 2024 | prnewswire.com‘Spoofing’ case might draw back curtain on high-speed trading firmsMarch 2, 2024 | ft.comNorthwest Biotherapeutics, Inc. (NWBO)February 29, 2024 | uk.finance.yahoo.comNorthwest Biotherapeutics Stock (OTC:NWBO), Short Interest ReportFebruary 23, 2024 | benzinga.comNorthwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory CertificationFebruary 7, 2024 | finance.yahoo.comNorthwest Biotherapeutics submits marketing application to UK MHRA for DCVax-LDecember 22, 2023 | msn.comNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For GlioblastomaDecember 21, 2023 | finanznachrichten.deNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For GlioblastomaDecember 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization ApplicationNovember 22, 2023 | finance.yahoo.comNorthwest Biotherapeutics Inc NWBOOctober 31, 2023 | morningstar.comNorthwest Bio: Another Small Filing DelayOctober 14, 2023 | msn.comNW Bio dips on announcing delay in submission of marketing application for DCVaxOctober 13, 2023 | seekingalpha.comNorthwest Biotherapeutics Shares Slide on Application DelayOctober 13, 2023 | marketwatch.comNorthwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization ApplicationOctober 13, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory BoardSeptember 12, 2023 | finance.yahoo.comNorthwest Bio: Is There Ever Going To Be A Right Time?August 17, 2023 | msn.comNorthwest Missouri State UniversityAugust 6, 2023 | usnews.comNorthwest HospitalAugust 4, 2023 | health.usnews.comWhy Northwest Bio Is Shunned by Savvy Health Care InvestorsJuly 15, 2023 | thestreet.comThree rounds of severe weather expected over the next 24 hours for Northwest FloridaJune 19, 2023 | pnj.com Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address NWBO Media Mentions By Week NWBO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWBO News Sentiment▼0.370.76▲Average Medical News Sentiment NWBO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWBO Articles This Week▼20▲NWBO Articles Average Week Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HCM News ACAD News APLS News AMRX News RXRX News IBRX News BHVN News VCEL News TWST News MTSR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWBO) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Northwest Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NWBO Stock Free NWBO Stock Alerts